Stock Research for ALXN

ALXN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ALXN Stock Chart & Research Data

The ALXN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALXN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ALXN Due diligence Resources & Stock Charts

The ALXN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ALXN Detailed Price Forecast - CNN Money CNN View ALXN Detailed Summary - Google Finance
Yahoo View ALXN Detailed Summary - Yahoo! Finance Zacks View ALXN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ALXN Trends & Analysis - Trade-Ideas Barrons View ALXN Major Holders - Barrons
NASDAQ View ALXN Call Transcripts - NASDAQ Seeking View ALXN Breaking News & Analysis - Seeking Alpha
Spotlight View ALXN Annual Report - CompanySpotlight.com OTC Report View ALXN OTC Short Report - OTCShortReport.com
TradeKing View ALXN Fundamentals - TradeKing Charts View ALXN SEC Filings - Bar Chart
WSJ View Historical Prices for ALXN - The WSJ Morningstar View Performance/Total Return for ALXN - Morningstar
MarketWatch View the Analyst Estimates for ALXN - MarketWatch CNBC View the Earnings History for ALXN - CNBC
StockMarketWatch View the ALXN Earnings - StockMarketWatch MacroAxis View ALXN Buy or Sell Recommendations - MacroAxis
Bullish View the ALXN Bullish Patterns - American Bulls Short Pains View ALXN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ALXN Stock Mentions - StockTwits PennyStocks View ALXN Stock Mentions - PennyStockTweets
Twitter View ALXN Stock Mentions - Twitter Invest Hub View ALXN Investment Forum News - Investor Hub
Yahoo View ALXN Stock Mentions - Yahoo! Message Board Seeking Alpha View ALXN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ALXN - SECform4.com Insider Cow View Insider Transactions for ALXN - Insider Cow
CNBC View ALXN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ALXN - OTC Markets
Yahoo View Insider Transactions for ALXN - Yahoo! Finance NASDAQ View Institutional Holdings for ALXN - NASDAQ


Stock Charts

FinViz View ALXN Stock Insight & Charts - FinViz.com StockCharts View ALXN Investment Charts - StockCharts.com
BarChart View ALXN Stock Overview & Charts - BarChart Trading View View ALXN User Generated Charts - Trading View




Latest Financial News for ALXN


IBD 50 Growth Stocks To Watch: After Climbing 403% From A 2009 Breakout, Can This Biotech Surge Again?
Posted on Wednesday March 20, 2019

Earnings are rising again and revenue growth is accelerating at Alexion Pharmaceuticals, one of the current top growth stocks to watch in the IBD 50.


Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases
Posted on Wednesday March 20, 2019

- Collaboration furthers Alexion’s complement leadership with expansion into peptide therapies -


Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody® Molecule
Posted on Wednesday March 20, 2019

Alexion Pharmaceuticals, Inc. (ALXN) and Affibody AB today announced a partnership to co-develop ABY-039 for rare Immunoglobulin G (IgG)-mediated autoimmune diseases. Currently in Phase 1 development, ABY-039 is a bivalent antibody-mimetic that targets the neonatal Fc receptor (FcRn).


See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.
Posted on Tuesday March 19, 2019

Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXNView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for ALXN with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ALXN. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding ALXN are favorable, with net inflows of $10.95 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.